Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wild

Showing results (521-530 of 738) with videos related to

Pageof 74
Sort By:
Pathology, Research and Practice|October 30, 2021
A novel 5x multiplex immunohistochemical staining reveals PSMA as a helpful marker in prostate cancer with low p504s expressionJan H Rüschoff, Steven Stratton, Esteban Roberts, et al.
Vaccine|December 12, 2001
PsaA (pneumococcal surface adhesin A) and PspA (pneumococcal surface protein A) DNA vaccines induce humoral and cellular immune responses against Streptococcus pneumoniaeE N Miyaji, W O Dias, M Gamberini, et al.
BMC Cancer|December 23, 2022
Increased HRD score in cisplatin resistant penile cancer cellsRia Winkelmann, Katrin Bankov, Claudia Döring, et al.
EMBO Molecular Medicine|April 23, 2013
Combined mutation of Vhl and Trp53 causes renal cysts and tumours in miceJoachim Albers, Michal Rajski, Désirée Schönenberger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2008
HER3 is a determinant for poor prognosis in melanomaMarkus Reschke, Daniela Mihic-Probst, Edward Htun van der Horst, et al.
Oncogene|July 27, 2007
The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylationJ Veeck, M Chorovicer, A Naami, et al.
Scientific Reports|November 2, 2022
Lumbar puncture safety and tolerability in premanifest and manifest Huntington's disease: a multi-analysis cross-sectional studyYara Refaat Hassan, Filipe Brogueira Rodrigues, Paul Zeun, et al.
Pathologie (Heidelberg, Germany)|February 19, 2024
[The model transferability of AI in digital pathology : Potential and reality]Robin S Mayer, Maximilian N Kinzler, Alexandra K Stoll, et al.
Paediatric and Perinatal Epidemiology|February 17, 2007
Determinants of developmental delay in infants aged 12 monthsRebecca F Slykerman, John M D Thompson, Phillipa M Clark, et al.
Journal of Clinical Pathology|August 8, 2015
Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancerCédric Poyet, Lorenz Buser, Filip Roudnicky, et al.
Pageof 74

Showing results (521-530 of 738) with videos related to

Sort By:
Pageof 74
Pathology, Research and Practice|October 30, 2021
A novel 5x multiplex immunohistochemical staining reveals PSMA as a helpful marker in prostate cancer with low p504s expressionJan H Rüschoff, Steven Stratton, Esteban Roberts, et al.
Vaccine|December 12, 2001
PsaA (pneumococcal surface adhesin A) and PspA (pneumococcal surface protein A) DNA vaccines induce humoral and cellular immune responses against Streptococcus pneumoniaeE N Miyaji, W O Dias, M Gamberini, et al.
BMC Cancer|December 23, 2022
Increased HRD score in cisplatin resistant penile cancer cellsRia Winkelmann, Katrin Bankov, Claudia Döring, et al.
EMBO Molecular Medicine|April 23, 2013
Combined mutation of Vhl and Trp53 causes renal cysts and tumours in miceJoachim Albers, Michal Rajski, Désirée Schönenberger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2008
HER3 is a determinant for poor prognosis in melanomaMarkus Reschke, Daniela Mihic-Probst, Edward Htun van der Horst, et al.
Oncogene|July 27, 2007
The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylationJ Veeck, M Chorovicer, A Naami, et al.
Scientific Reports|November 2, 2022
Lumbar puncture safety and tolerability in premanifest and manifest Huntington's disease: a multi-analysis cross-sectional studyYara Refaat Hassan, Filipe Brogueira Rodrigues, Paul Zeun, et al.
Pathologie (Heidelberg, Germany)|February 19, 2024
[The model transferability of AI in digital pathology : Potential and reality]Robin S Mayer, Maximilian N Kinzler, Alexandra K Stoll, et al.
Paediatric and Perinatal Epidemiology|February 17, 2007
Determinants of developmental delay in infants aged 12 monthsRebecca F Slykerman, John M D Thompson, Phillipa M Clark, et al.
Journal of Clinical Pathology|August 8, 2015
Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancerCédric Poyet, Lorenz Buser, Filip Roudnicky, et al.
Pageof 74